Agema, Willem R P <br/><br/>
Pharmacogenetics of the CD14 endotoxin receptor polymorphism and progression of coronary atherosclerosis.  [electronic resource] 

 -  Thrombosis and haemostasis  May 2004 
 - 986-90 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0340-6245 
<br/><br/><label>Standard No.: </label>10.1160/TH03-11-0668  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Coronary Artery Disease--drug therapy<br/>Disease Progression<br/>Drug Resistance--genetics<br/>Genotype<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Lipopolysaccharide Receptors--genetics<br/>Middle Aged<br/>Pharmacogenetics<br/>Polymorphism, Single Nucleotide--physiology<br/>Pravastatin--pharmacology<br/>Promoter Regions, Genetic--genetics<br/>Receptors, Immunologic--genetics